Ticker Details
Savara Inc. Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases.
IPO Date:	March 11, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.2B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.13 | 3.10%
Avg Daily Range (30 D):	$0.12 | 2.15%
Avg Daily Range (90 D):	$0.16 | 2.70%

Institutional Daily Volume
Avg Daily Volume:	.66M
Avg Daily Volume (30 D):	1.3M
Avg Daily Volume (90 D):	1.82M

Trade Size
Avg Trade Size (Sh.):	162
Avg Trade Size (Sh.) (30 D):	84
Avg Trade Size (Sh.) (90 D):	111

Institutional Trades
Total Institutional Trades:	581
Avg Institutional Trade:	$1.61M
Avg Institutional Trade (30 D):	$2.05M
Avg Institutional Trade (90 D):	$1.53M
Avg Institutional Trade Volume:	.36M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.82M
Avg Closing Trade (30 D):	$1.94M
Avg Closing Trade (90 D):	$1.77M
Avg Closing Volume:	399.65K

News

Mar 6, 2026 @ 9:05 PM Savara Provides Regulatory Update on the MOLBREEVI... Source: Business Wire

Mar 4, 2026 @ 9:05 PM Savara Announces Participation in 2026 Citizens Li... Source: Business Wire

Feb 4, 2026 @ 9:05 PM Savara Announces Participation in Upcoming Investo... Source: Business Wire

Jan 24, 2026 @ 4:38 PM SAVARA INVESTIGATION ALERT: Bragar Eagel & Squire,... Source: Bragar Eagel & Squire, P.C.

Dec 17, 2025 @ 1:05 PM Savara Announces Participation in the 44th Annual ... Source: Business Wire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.53	$-.13	$-.53
Diluted EPS	$-.53	$-.13	$-.53
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-118.84M	$-32.24M	$-118.84M
Operating Income / Loss	$-123.55M	$-33.42M	$-123.55M
Cost of Revenue
Net Cash Flow	$18.33M	$16.94M	$18.33M
PE Ratio

Splits
Apr 28, 2017	1:70
Apr 26, 2010	1:25
Jul 26, 2000	1:2